ari hakimi

Kidney Cancer surgeon/scientist @MSKCancerCenter . Co-leader of Translational Kidney Cancer Program and Assistant PD @urologymsk Tweets my own.

[Vince D’Andrea, MD @VinceDAndreaMD]

Thank you to my outstanding mentors, both past and present. @mouwlab @MattMossanen @RichMatulewicz @eugene_pietzak @DSolit @arihakimi @UrologyMSK

[Ziad Bakouny, MD, MSc @ZiadBakouny]

Really awesome poster by urologic oncology fellow extraordinaire @VinceDAndreaMD with @DrDarrenFeldman @DSolit #SamFunt on genomic determinants of cisplatin resistance in germ cell tumors!
@MSKCancerCenter @UrologyMSK @MSK_DeptOfMed

@ConquerCancerFd @ASCO #ASCO26

[UrologyMSK @UrologyMSK]

Now published in @ScienceMagazine by @UrologyMSK @arihakimi et al:

Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
https://t.co/LeYzmqrH5E

[ari hakimi @arihakimi]

Truly a privilege to work with such a rising ⭐️!!

[Ziad Bakouny, MD, MSc @ZiadBakouny]

Thrilled to receive the Gerstner Physician Scholars’ grant!
The grant will support our work for the next 3 years on mitochondrial DNA mutations in cancer.

Very thankful for the mentorship from Craig Thompson, @EdReznik, @motzermd, @arihakimi and many others!
@MSK_DeptOfMed

[Ziad Bakouny, MD, MSc @ZiadBakouny]

Thrilled to receive the Gerstner Physician Scholars’ grant!
The grant will support our work for the next 3 years on mitochondrial DNA mutations in cancer.

Very thankful for the mentorship from Craig Thompson, @EdReznik, @motzermd, @arihakimi and many others!
@MSK_DeptOfMed

[UrologyMSK @UrologyMSK]

Special to celebrate the retirement of the legendary Pramod Sogani after his 54 (!!) year career at @MSKCancerCenter! Amongst his many accomplishment Dr Sogani served as president of the @AmerUrological

[Dr. Anthony Letai @NCIDirector]

I’ve heard concerns about @theNCI funding in FY26—especially about the number of awards issued so far. Here’s some context. 🧵

[Dr. Anthony Letai @NCIDirector]

🧵 During today’s National Cancer Advisory Board (#NCAB) meeting, I shared updates on where NCI stands—and where we’re headed.

I see a research enterprise that is steady, focused, and ready to accelerate progress against cancer.

Here are a few highlights:

[Peter Black @pcvblack]

Big thank you to @arihakimi for visiting us and sharing your insights and energy. Expecting @MTDawidek to build on some of this with clinical and translational programs in #kidneycancer at @VanProstateCtr. Thanks also to @UroOnc for generous support of this visit!

[ari hakimi @arihakimi]

Was a true honor to be at a place that exemplifies clinical and research excellence!

[Mark Dawidek @MTDawidek]

An honour to host exemplary surgeon-scientist @arihakimi at @UBCUrology and @VanProstateCtr as our @UroOnc Visiting Professor. Inspiring work and vision in kidney cancer. A great opportunity for trainees and faculty to interact and exchange ideas across the clinic and lab.

[Mark Dawidek @MTDawidek]

An honour to host exemplary surgeon-scientist @arihakimi at @UBCUrology and @VanProstateCtr as our @UroOnc Visiting Professor. Inspiring work and vision in kidney cancer. A great opportunity for trainees and faculty to interact and exchange ideas across the clinic and lab.

[Katya Vinogradova @katenokv]

Cysteine reactivity profiling together with functional follow up studies highlight signaling and stress pathways linked to this metabolic insufficiency, including MAPK/JNK, p53/DNA damage, ER stress, proteasome regulation, and other proteome-wide effects.

[Downstate Urology @downstateuro]

Huge congratulations to @awiner24 on receiving the 2026 Young Urologist of the Year Award!

Your leadership, mentorship, and unwavering commitment to excellence continue to elevate our program and inspire every resident lucky enough to train under you.

[ari hakimi @arihakimi]

Check out our (@EdReznik @MVossMD) commentary in @NatureMedicine on two phenomenal papers from @kaelin_lab and @JBrugarolas on the role of Hif2 inhibition and cachexia is kidney cancer!

https://t.co/0E5woNqUT6

[ari hakimi @arihakimi]

Great night out with our all star fellows at #SUO2025 lo

[ari hakimi @arihakimi]

@rovingatuscap @UroOnc @PayalKapur5 @drmehrarohit @SUO_YUO @GU_Path_Society @IntSocUropath @UMichPath @MichelleDunno17 @Williamson_SR @LaraHarikMD @JaneNguyen44 @TheUSCAP @Uroweb Lots of 🧠power in that pic!

[ari hakimi @arihakimi]

@YashKhandwalaMD @UrologyMSK @EUplatinum Phenomenal work by @YashKhandwalaMD looking out the role of pathologic response and long term clinical outcomes following ICI therapy in kidney cancer

[Ed Reznik @EdReznik]

Today we're releasing a preprint describing the incidence, physiology + molecular features of cachexia in 60,000 MSK patients. A herculean effort by Venise Jan Castillon, Amy Xie, and our whole lab. https://t.co/vBac7r2ipi

[ari hakimi @arihakimi]

@KSusztak Amazing as usual!!

[Samir Zaidi, MD, PhD @samirzaidi]

Grateful for the opportunity to present our work on using mouse organoids to model RCC. Inspiring to be surround by such a insightful community of scientists. @YaleCancer @arihakimi @KidneyCancer #Zaidilab